118 related articles for article (PubMed ID: 14994374)
1. Sensitive measurement of fragmented red cell population using flow cytometry, and its application for estimating thrombotic microangiopathy after stem cell transplantation.
Toba K; Tsuchiyama J; Hashimoto S; Ichida T; Kato K; Watanabe K; Furukawa T; Narita M; Takahashi M; Aizawa Y
Cytometry B Clin Cytom; 2004 Mar; 58(1):39-46. PubMed ID: 14994374
[TBL] [Abstract][Full Text] [Related]
2. The effectiveness of measuring for fragmented red cells using an automated hematology analyzer in patients with thrombotic microangiopathy.
Abe Y; Wada H; Yamada E; Noda M; Ikejiri M; Nishioka J; Kobayashi T; Matsumoto T; Masuya M; Isaji S; Usui M; Uemoto S; Katayama N; Nobori T
Clin Appl Thromb Hemost; 2009; 15(3):257-62. PubMed ID: 18603539
[TBL] [Abstract][Full Text] [Related]
3. Fragmented Red Cell as a Possible Favorable Prognostic Marker of Hematopoietic Stem Cell Transplantation Associated Thrombotic Microangiopathy.
Jekarl DW; Kim Y; Lim J; Kim M; Han K; Cho B; Kim HK; Min WS; Min CK
J Clin Lab Anal; 2015 Nov; 29(6):444-50. PubMed ID: 25385174
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of sequential automated analysis of fragmented red blood cells for the differential diagnosis of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome following allogeneic hematopoietic cell transplantation.
Imoto S; Murayama T; Nagai K; Hirabayashi N; Tanaka C; Misawa M; Kawasaki K; Mizuno I; Koizumi T; Kajimoto K; Takahashi T; Hara H; Kumagai S; Saigo K
Lab Hematol; 2005; 11(2):131-6. PubMed ID: 16024337
[TBL] [Abstract][Full Text] [Related]
5. [Fragmented red cells are the major cause of spuriously high platelet counts in patients with fragmented red cells when counts are obtained by automated blood cell counter].
Nishiyama M; Hayashi S; Futsukaichi Y; Suehisa E; Kurata Y
Rinsho Byori; 2005 Oct; 53(10):898-903. PubMed ID: 16296335
[TBL] [Abstract][Full Text] [Related]
6. Heparin-induced thrombocytopenia antibody and the pathogenesis of thrombotic microangiopathy after stem cell transplantation.
Takatsuka H; Nakajima T; Nomura K; Wakae T; Toda A; Itoi H; Okada M; Misawa M; Hara H
Clin Transplant; 2005 Jun; 19(3):418-22. PubMed ID: 15877808
[TBL] [Abstract][Full Text] [Related]
7. Quantification of red blood cell fragmentation by the automated hematology analyzer XE-2100 in patients with living donor liver transplantation.
Banno S; Ito Y; Tanaka C; Hori T; Fujimoto K; Suzuki T; Hashimoto T; Ueda R; Mizokami M
Clin Lab Haematol; 2005 Oct; 27(5):292-6. PubMed ID: 16178907
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: The incidence is not reduced.
Shimoni A; Yeshurun M; Hardan I; Avigdor A; Ben-Bassat I; Nagler A
Biol Blood Marrow Transplant; 2004 Jul; 10(7):484-93. PubMed ID: 15205669
[TBL] [Abstract][Full Text] [Related]
9. Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.
Uderzo C; Bonanomi S; Busca A; Renoldi M; Ferrari P; Iacobelli M; Morreale G; Lanino E; Annaloro C; Volpe AD; Alessandrino P; Longoni D; Locatelli F; Sangalli H; Rovelli A
Transplantation; 2006 Sep; 82(5):638-44. PubMed ID: 16969286
[TBL] [Abstract][Full Text] [Related]
10. Validation of recently proposed consensus criteria for thrombotic microangiopathy after allogeneic hematopoietic stem-cell transplantation.
Cho BS; Yahng SA; Lee SE; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Park CW
Transplantation; 2010 Oct; 90(8):918-26. PubMed ID: 20717073
[TBL] [Abstract][Full Text] [Related]
11. Clinical impact of thrombotic microangiopathy on the outcome of patients with acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Cho BS; Min CK; Eom KS; Kim YJ; Kim HJ; Lee S; Cho SG; Kim Y; Kim DW; Lee JW; Min WS; Kim CC
Bone Marrow Transplant; 2008 May; 41(9):813-20. PubMed ID: 18209725
[TBL] [Abstract][Full Text] [Related]
12. Early clinical indicators of transplant-associated thrombotic microangiopathy in pediatric neuroblastoma patients undergoing auto-SCT.
Laskin BL; Goebel J; Davies SM; Khoury JC; Bleesing JJ; Mehta PA; Filipovich AH; Paff ZN; Lawrence JM; Yin HJ; Pinkard SL; Jodele S
Bone Marrow Transplant; 2011 May; 46(5):682-9. PubMed ID: 20697372
[TBL] [Abstract][Full Text] [Related]
13. Risk factor analysis for thrombotic microangiopathy after reduced-intensity or myeloablative allogeneic hematopoietic stem cell transplantation.
Nakamae H; Yamane T; Hasegawa T; Nakamae M; Terada Y; Hagihara K; Ohta K; Hino M
Am J Hematol; 2006 Jul; 81(7):525-31. PubMed ID: 16755559
[TBL] [Abstract][Full Text] [Related]
14. Thrombotic microangiopathy after ABO-incompatible living donor liver transplantation: a case report.
Oya H; Sato Y; Yamamoto S; Nakatsuka H; Kobayashi T; Watanabe T; Kokai H; Hatakeyama K
Transplant Proc; 2008 Oct; 40(8):2549-51. PubMed ID: 18929797
[TBL] [Abstract][Full Text] [Related]
15. Posttransplant thrombotic microangiopathy: sensitivity of proposed new diagnostic criteria.
Kennedy GA; Bleakley S; Butler J; Mudie K; Kearey N; Durrant S
Transfusion; 2009 Sep; 49(9):1884-9. PubMed ID: 19453982
[TBL] [Abstract][Full Text] [Related]
16. Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: an autopsy study.
Siami K; Kojouri K; Swisher KK; Selby GB; George JN; Laszik ZG
Transplantation; 2008 Jan; 85(1):22-8. PubMed ID: 18192907
[TBL] [Abstract][Full Text] [Related]
17. Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.
Cutler C; Henry NL; Magee C; Li S; Kim HT; Alyea E; Ho V; Lee SJ; Soiffer R; Antin JH
Biol Blood Marrow Transplant; 2005 Jul; 11(7):551-7. PubMed ID: 15983555
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics of thrombotic microangiopathy following ABO incompatible living donor liver transplantation.
Miyata R; Shimazu M; Tanabe M; Kawachi S; Hoshino K; Wakabayashi G; Kawai Y; Kitajima M
Liver Transpl; 2007 Oct; 13(10):1455-62. PubMed ID: 17902122
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-17-producing T-helper cells as new potential player mediating graft-versus-host disease in patients undergoing allogeneic stem-cell transplantation.
Dander E; Balduzzi A; Zappa G; Lucchini G; Perseghin P; Andrè V; Todisco E; Rahal D; Migliavacca M; Longoni D; Solinas G; Villa A; Berti E; Mina PD; Parma M; Allavena P; Biagi E; Rovelli A; Biondi A; D'Amico G
Transplantation; 2009 Dec; 88(11):1261-72. PubMed ID: 19996925
[TBL] [Abstract][Full Text] [Related]
20. Serum neutrophil extracellular trap levels predict thrombotic microangiopathy after allogeneic stem cell transplantation.
Arai Y; Yamashita K; Mizugishi K; Watanabe T; Sakamoto S; Kitano T; Kondo T; Kawabata H; Kadowaki N; Takaori-Kondo A
Biol Blood Marrow Transplant; 2013 Dec; 19(12):1683-9. PubMed ID: 24055655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
